These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31723004)

  • 21. The role genes encoding of killer cell immunoglobulin-like receptors (KIRs) and their ligands in susceptibility to and progression of HIV infection.
    Błachowicz O; Zwolińska K
    Postepy Hig Med Dosw (Online); 2016 Dec; 70(0):1409-1423. PubMed ID: 28100849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1/S1.
    Alicata C; Pende D; Meazza R; Canevali P; Loiacono F; Bertaina A; Locatelli F; Nemat-Gorgani N; Guethlein LA; Parham P; Moretta L; Moretta A; Bottino C; Norman PJ; Falco M
    Eur J Immunol; 2016 Jun; 46(6):1511-7. PubMed ID: 26990677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retention.
    Taner SB; Pando MJ; Roberts A; Schellekens J; Marsh SG; Malmberg KJ; Parham P; Brodsky FM
    J Immunol; 2011 Jan; 186(1):62-72. PubMed ID: 21115737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function.
    D'Amico S; D'Alicandro V; Compagnone M; Tempora P; Guida G; Romania P; Lucarini V; Melaiu O; Falco M; Algeri M; Pende D; Cifaldi L; Fruci D
    Front Immunol; 2021; 12():778103. PubMed ID: 34917091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activation.
    Tang CC; Isitman G; Bruneau J; Tremblay C; Bernard NF; Kent SJ; Parsons MS
    Clin Exp Immunol; 2015 Aug; 181(2):275-85. PubMed ID: 25644502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.
    O'Connor GM; Guinan KJ; Cunningham RT; Middleton D; Parham P; Gardiner CM
    J Immunol; 2007 Jan; 178(1):235-41. PubMed ID: 17182560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective genotypes in HIV infection reflect superior function of KIR3DS1+ over KIR3DL1+ CD8+ T cells.
    Zipperlen K; Gallant M; Stapleton S; Heath J; Barrett L; Grant M
    Immunol Cell Biol; 2015 Jan; 93(1):67-76. PubMed ID: 25112829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1.
    Stern M; Ruggeri L; Capanni M; Mancusi A; Velardi A
    Blood; 2008 Aug; 112(3):708-10. PubMed ID: 18502829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KIR3DL1 Allotype-Dependent Modulation of NK Cell Immunity against Chronic Myeloid Leukemia.
    Izumi K; Shindo T; Ngo HT; Nakayama-Hosoya K; Akahane K; Tamai M; Nguyen TTT; Kawana-Tachikawa A; Inukai T; Takaori-Kondo A
    Immunohorizons; 2021 Aug; 5(8):687-702. PubMed ID: 34433624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KIR and HLA genotypes predictive of low-affinity interactions are associated with lower relapse in autologous hematopoietic cell transplantation for acute myeloid leukemia.
    Marra J; Greene J; Hwang J; Du J; Damon L; Martin T; Venstrom JM
    J Immunol; 2015 May; 194(9):4222-30. PubMed ID: 25810393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cell-mediated inhibition of HIV replication in autologous CD4 targets.
    Song R; Lisovsky I; Lebouché B; Routy JP; Bruneau J; Bernard NF
    PLoS Pathog; 2014 Jan; 10(1):e1003867. PubMed ID: 24453969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA Mismatching Favoring Host-Versus-Graft NK Cell Activity Via KIR3DL1 Is Associated With Improved Outcomes Following Lung Transplantation.
    Greenland JR; Sun H; Calabrese D; Chong T; Singer JP; Kukreja J; Hays SR; Golden JA; Caughey GH; Venstrom JM; Rajalingam R
    Am J Transplant; 2017 Aug; 17(8):2192-2199. PubMed ID: 28375571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of a dengue virus NS1-derived peptide with the inhibitory receptor KIR3DL1 on natural killer cells.
    Townsley E; O'Connor G; Cosgrove C; Woda M; Co M; Thomas SJ; Kalayanarooj S; Yoon IK; Nisalak A; Srikiatkhachorn A; Green S; Stephens HA; Gostick E; Price DA; Carrington M; Alter G; McVicar DW; Rothman AL; Mathew A
    Clin Exp Immunol; 2016 Mar; 183(3):419-30. PubMed ID: 26439909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1.
    O'Connor GM; Vivian JP; Gostick E; Pymm P; Lafont BA; Price DA; Rossjohn J; Brooks AG; McVicar DW
    J Virol; 2015 May; 89(10):5213-21. PubMed ID: 25740999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KIR3DL1-Negative CD8 T Cells and KIR3DL1-Negative Natural Killer Cells Contribute to the Advantageous Control of Early Human Immunodeficiency Virus Type 1 Infection in
    Zhang X; Lu X; Moog C; Yuan L; Liu Z; Li Z; Xia W; Zhou Y; Wu H; Zhang T; Su B
    Front Immunol; 2018; 9():1855. PubMed ID: 30147699
    [No Abstract]   [Full Text] [Related]  

  • 36. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
    Bakker AB; Phillips JH; Figdor CG; Lanier LL
    J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
    Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA class I NK-epitopes and KIR diversities in patients with multiple myeloma.
    Beelen NA; Molenbroeck SJJ; Groeneveld L; Voorter CE; Bos GMJ; Wieten L
    Immunogenetics; 2024 Jun; 76(3):155-164. PubMed ID: 38478091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B.
    Thananchai H; Gillespie G; Martin MP; Bashirova A; Yawata N; Yawata M; Easterbrook P; McVicar DW; Maenaka K; Parham P; Carrington M; Dong T; Rowland-Jones S
    J Immunol; 2007 Jan; 178(1):33-7. PubMed ID: 17182537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variable NK cell receptors exemplified by human KIR3DL1/S1.
    Parham P; Norman PJ; Abi-Rached L; Guethlein LA
    J Immunol; 2011 Jul; 187(1):11-9. PubMed ID: 21690332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.